A 58 year old patient is 18 days post allogeneic stem cell transplant as treatment for myelodysplastic syndrome with secondary acute myeloid leukaemia. | Medibuddy
30th July 2023

A 58 year old patient is 18 days post allogeneic stem cell transplant as treatment for myelodysplastic syndrome with secondary acute myeloid leukaemia.

A 58 year old patient is 18 days post allogeneic stem cell transplant as treatment for myelodysplastic syndrome with secondary acute myeloid leukaemia. Despite current IV meropenem and vancomycin treatment, she is febrile with a cough. High resolution CT shows bilateral nodules with some cavitation. Serum galactomannan is strongly positive.

What empirical treatment would be most appropriate to commence?

Select the SINGLE most appropriate option from the list below. Select ONE option only.

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.